Transfusion in Sickle Cell Disease: Risk Factors for Alloimmunization
- Status
- COMPLETED
- Phase
- NA
Clinical Trials Related to Sickle Cell Disease
Related studies linked through entity extraction aliases.
Risk Factors for Allo-immunization in Sickle Cell Disease
- Status
- WITHDRAWN
- Phase
- N/A
A Study of IMR-687 in Adult Participants With Sickle Cell Anemia (Homozygous HbSS or Sickle-β0 Thalassemia)
- Status
- COMPLETED
- Phase
- PHASE2
Role of Virtual Reality (VR) in Patients With Sickle Cell Disease (SCD)
- Status
- TERMINATED
- Phase
- NA
HRV-B for Symptom Management in Sickle Cell Patients
- Status
- COMPLETED
- Phase
- NA
Epidemiology of Silent and Overt Strokes in Sickle Cell Disease
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- N/A
Implication of the Oxydative Stress in the Pathophysiology of Sickle Cell Anemia:
- Status
- COMPLETED
- Phase
- NA
Epidemiology and Pathophysiological Mechanisms of HTAP in SS and SC Children in Martinique and Guadeloupe.
- Status
- COMPLETED
- Phase
- NA
Haploidentical Allogeneic Hematopoietic Stem Cell Transplantation (HaploHCT) Following Reduced Intensity Conditioning (RIC) for Selected High Risk Non-Malignant Diseases
- Status
- TERMINATED
- Phase
- PHASE2
Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease
- Status
- RECRUITING
- Phase
- NA
Substudy of CADRE: for People With Extreme Phenotype: BIOCADRE
- Status
- UNKNOWN
- Phase
- N/A
Re-Aiming at Hydroxyurea Adherence for Sickle Cell With mHealth
- Status
- COMPLETED
- Phase
- N/A
Fludarabine Phosphate, Cyclophosphamide, Total Body Irradiation, and Donor Stem Cell Transplant in Treating Patients With Blood Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Sickle-cell Disease Registry of the GPOH
- Status
- RECRUITING
- Phase
- N/A
Mesenchymal Stromal Cells for Haplo Hematopoietic Cell Transplantation for Sickle Cell Disease
- Status
- WITHDRAWN
- Phase
- PHASE1
Adjuvant Low-dose Ketamine in Pediatric Sickle Cell Vaso-occlusive Crisis
- Status
- COMPLETED
- Phase
- PHASE2
Zinc Supplementation in Children With Sickle Cell Disease in Western Kenya
- Status
- COMPLETED
- Phase
- NA
Gaming Technology to Engage Adolescent Sickle Cell Patients in Pain Management
- Status
- COMPLETED
- Phase
- NA
Sickle Cell Disease: Targeting Alloantibody Formation Reduction; Risk Factors, and Genetics
- Status
- UNKNOWN
- Phase
- N/A
A Study of the Effect of IW-1701 (Olinciguat), a Stimulator of Soluble Guanylate Cyclase (sGC), on Patients With Sickle Cell Disease (SCD)
- Status
- COMPLETED
- Phase
- PHASE2